Henri Doods

6.4k total citations · 1 hit paper
107 papers, 5.3k citations indexed

About

Henri Doods is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Henri Doods has authored 107 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cellular and Molecular Neuroscience, 46 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in Henri Doods's work include Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (38 papers) and Pain Mechanisms and Treatments (15 papers). Henri Doods is often cited by papers focused on Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (38 papers) and Pain Mechanisms and Treatments (15 papers). Henri Doods collaborates with scholars based in Germany, United States and South Korea. Henri Doods's co-authors include K Rudolf, H. Wieland, Wolfgang Eberlein, Michael Entzeroth, Wolfhard Engel, Annette G. Beck‐Sickinger, Dongmei Wu, Wolfgang Wienen, Thomas C. Westfall and Martin C. Michel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Henri Doods

107 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors

1998 736 citations Annette G. Beck‐Sickinger, Henri Doods et al. profile →

Peers

Countries citing papers authored by Henri Doods

Since Specialization

Citations

This map shows the geographic impact of Henri Doods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Doods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Doods more than expected).

Fields of papers citing papers by Henri Doods

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Doods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Doods. The network helps show where Henri Doods may publish in the future.

Co-authorship network of co-authors of Henri Doods

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Doods. A scholar is included among the top collaborators of Henri Doods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Doods. Henri Doods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice 2023 ·European journal of medical research ·(unknown), Saeed Nasseri, (unknown), (unknown), Dongwon Lee, Anton Pekcec, Henri Doods, Dongmei Wu	2
2	Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice 2022 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), Kwan Seob Shim, Anton Pekcec, Dongwon Lee, Henri Doods, Dongmei Wu	8
3	Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic pain 2018 ·Behavioural Brain Research ·Kris Rutten, (unknown), (unknown), Henri Doods, Thomas Christoph, Anton Pekcec	20
4	Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain 2016 ·Neuroscience Letters ·(unknown), Henri Doods, Rolf‐Detlef Treede, Angelo Ceci	25
5	Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy 2015 ·Osteoarthritis and Cartilage ·(unknown), Janet R. Nicholson, Henri Doods, Anton Pekcec	45
6	The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats 2013 ·Pain ·Silke Hirsch, Laura Corradini, Stefan Just, Kirsten Arndt, Henri Doods	61
7	Sabiporide Reduces Ischemia-Induced Arrhythmias and Myocardial Infarction and Attenuates ERK Phosphorylation and iNOS Induction in Rats 2012 ·BioMed Research International ·Henri Doods, Dongmei Wu	9
8	Effects of a Novel Bradykinin B1 Receptor Antagonist and Angiotensin II Receptor Blockade on Experimental Myocardial Infarction in Rats 2012 ·PLoS ONE ·Dongmei Wu, Xinchun Lin, (unknown), Tobias Hildebrandt, Henri Doods	14
9	In Vivo Human MCP-1 Transfection in Porcine Arteries by Intravascular Electroporation 2005 ·Pharmaceutical Research ·Randolph Seidler, (unknown), (unknown), (unknown), (unknown), Dietmar Rabussay, Henri Doods, Martin Lenter	7
10	Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat 2004 ·British Journal of Pharmacology ·Kenneth A. Petersen, Steffen Birk, Henri Doods, Lars Edvinsson, Jes Olesen	107
11	Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamus 2003 ·Regulatory Peptides ·(unknown), Marcus Schindler, Mario Beilmann, Bradford S. Hamilton, Henri Doods, H. Wieland	6
12	Agonist and antagonist activities on human NPFF₂ receptors of the NPY ligands GR231118 and BIBP3226 2001 ·British Journal of Pharmacology ·Catherine Mollereau, Christine Gouardères, Yvan Dumont, Masato Kotani, Michel Detheux, Henri Doods, Marc Parmentier, Rémi Quirion, Jean‐Marie Zajac	51
13	The role of NPY in metabolic homeostasis: implications for obesity therapy 2000 ·Expert Opinion on Investigational Drugs ·H. Wieland, Bradford S. Hamilton, (unknown), Henri Doods	34
14	Effects of BIIB513 on ischemia-induced arrhythmias and myocardial infarction in anesthetized rats 2000 ·Basic Research in Cardiology ·Dongmei Wu, (unknown), Randolph Seidler, Henri Doods	17
15	Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist 2000 ·British Journal of Pharmacology ·Henri Doods, (unknown), Dongmei Wu, Michael Entzeroth, K Rudolf, Wolfhard Engel, Wolfgang Eberlein	386
16	BIIE0246 選択的で高親和性のニューロペプチドY Y 2 受容体きっ抗薬 1999 ·European Journal of Pharmacology ·Henri Doods, Wolfram Gaida, H. Wieland, (unknown), Gerd Schnorrenberg, (unknown), Werner Engel, Wolfgang Eberlein, K Rudolf	5
17	Probing of the neuropeptide Y−Y₁‐receptors interaction with anti‐receptor antibodies 1998 ·European Journal of Biochemistry ·H. Wieland, (unknown), Henri Doods, Annette G. Beck‐Sickinger	19
18	Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines 1995 ·Peptides ·H. Wieland, Klaus‐Dieter Willim, Henri Doods	30
19	The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 1994 ·European Journal of Pharmacology ·K Rudolf, Wolfgang Eberlein, Wolfhard Engel, H. Wieland, (unknown), Michael Entzeroth, Wolfgang Wienen, Annette G. Beck‐Sickinger, Henri Doods	337
20	The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs 1993 ·European Journal of Pharmacology ·J. C. A. van Meel, (unknown), R. Haigh, Wolfgang Wienen, M. Pairet, Marco Turconi, Henri Doods	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact